For citations:
lisina E.G., Siordiya N.T., Butylin P.A., Silyutina A.A., Matyukhina N.M., Senderova O.M., Fokina E.S., Ovsepyan V.A., Lomaia E.G., Zaritskiy A.Yu. CLINICAL AND LABORATORY FEATURES OF ESSENTIAL THROMBOCYTOSIS AND PRIMARY MYELOFIBROSIS DEPENDING ON JAK2 AND CALR1 MUTATION STATUS. Oncohematology. 2017;12(3):8-16. (In Russ.) https://doi.org/10.17650/1818-8346-2017-12-3-8-16
Email this article 